These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 32329752)
41. In vitro studies on nobiletin isolated from citrus plants and the bioactive metabolites, inhibitory action against gelatinase enzymatic activity and the molecular mechanisms in human retinal Müller cell line. Miyata Y; Nagase T; Katsura Y; Takahashi H; Natsugari H; Oshitari T; Kosano H Biomed Pharmacother; 2017 Sep; 93():70-80. PubMed ID: 28623785 [TBL] [Abstract][Full Text] [Related]
42. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Hirano T; Abe K; Gotoh M; Oka K Br J Cancer; 1995 Dec; 72(6):1380-8. PubMed ID: 8519648 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of bacterial mutagenesis by Citrus flavonoids. Calomme M; Pieters L; Vlietinck A; Vanden Berghe D Planta Med; 1996 Jun; 62(3):222-6. PubMed ID: 8693033 [TBL] [Abstract][Full Text] [Related]
44. Management of diabetic complications through fruit flavonoids as a natural remedy. Tanveer A; Akram K; Farooq U; Hayat Z; Shafi A Crit Rev Food Sci Nutr; 2017 May; 57(7):1411-1422. PubMed ID: 26065867 [TBL] [Abstract][Full Text] [Related]
45. Nobiletin: a citrus flavonoid displaying potent physiological activity. Noguchi S; Atsumi H; Iwao Y; Kan T; Itai S Acta Crystallogr C Struct Chem; 2016 Feb; 72(Pt 2):124-7. PubMed ID: 26846496 [TBL] [Abstract][Full Text] [Related]
46. Flavones as a Privileged Scaffold in Drug Discovery: Current Developments. Boniface PK; Elizabeth FI Curr Org Synth; 2019; 16(7):968-1001. PubMed ID: 31984880 [TBL] [Abstract][Full Text] [Related]
47. Flavones: Six Selected Flavones and Their Related Signaling Pathways That Induce Apoptosis in Cancer. Jeong SH; Kim HH; Ha SE; Park MY; Bhosale PB; Abusaliya A; Park KI; Heo JD; Kim HW; Kim GS Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142874 [TBL] [Abstract][Full Text] [Related]
48. Flavonoid-Based Cancer Therapy: An Updated Review. Hosseinzadeh E; Hassanzadeh A; Marofi F; Alivand MR; Solali S Anticancer Agents Med Chem; 2020; 20(12):1398-1414. PubMed ID: 32324520 [TBL] [Abstract][Full Text] [Related]
49. Citrus Tangeretin Improves Skeletal Muscle Mitochondrial Biogenesis via Activating the AMPK-PGC1-α Pathway In Vitro and In Vivo: A Possible Mechanism for Its Beneficial Effect on Physical Performance. Kou G; Li Z; Wu C; Liu Y; Hu Y; Guo L; Xu X; Zhou Z J Agric Food Chem; 2018 Nov; 66(45):11917-11925. PubMed ID: 30369237 [TBL] [Abstract][Full Text] [Related]
50. Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. Murakami A; Nakamura Y; Ohto Y; Yano M; Koshiba T; Koshimizu K; Tokuda H; Nishino H; Ohigashi H Biofactors; 2000; 12(1-4):187-92. PubMed ID: 11216485 [TBL] [Abstract][Full Text] [Related]
52. A Pharmacological Appraisal of Neuroprotective and Neurorestorative Flavonoids Against Neurodegenerative Diseases. Zhao J; Zhu M; Kumar M; Ngo FY; Li Y; Lao L; Rong J CNS Neurol Disord Drug Targets; 2019; 18(2):103-114. PubMed ID: 30394219 [TBL] [Abstract][Full Text] [Related]
53. Inhibitory effects of Citrus flavonoids on starch digestion and antihyperglycemic effects in HepG2 cells. Shen W; Xu Y; Lu YH J Agric Food Chem; 2012 Sep; 60(38):9609-19. PubMed ID: 22958058 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of tamoxifen's therapeutic benefit by tangeretin in mammary cancer. Depypere HT; Bracke ME; Boterberg T; Mareel MM; Nuytinck M; Vennekens K; Serreyn R Eur J Cancer; 2000 Sep; 36 Suppl 4():S73. PubMed ID: 11056327 [TBL] [Abstract][Full Text] [Related]
55. A Scientometric Study to a Critical Review on Promising Anticancer and Neuroprotective Compounds: Citrus Flavonoids. Qiu M; Wei W; Zhang J; Wang H; Bai Y; Guo DA Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978916 [TBL] [Abstract][Full Text] [Related]
56. Important Flavonoids and Their Role as a Therapeutic Agent. Ullah A; Munir S; Badshah SL; Khan N; Ghani L; Poulson BG; Emwas AH; Jaremko M Molecules; 2020 Nov; 25(22):. PubMed ID: 33187049 [TBL] [Abstract][Full Text] [Related]
57. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Manthey JA; Grohmann K; Guthrie N Curr Med Chem; 2001 Feb; 8(2):135-53. PubMed ID: 11172671 [TBL] [Abstract][Full Text] [Related]
58. Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. Choi SY; Ko HC; Ko SY; Hwang JH; Park JG; Kang SH; Han SH; Yun SH; Kim SJ Biol Pharm Bull; 2007 Apr; 30(4):772-8. PubMed ID: 17409518 [TBL] [Abstract][Full Text] [Related]
59. Tangeretin as an adjuvant and chemotherapeutic sensitizer against various types of cancers: a comparative overview. Alhamad DW; Elgendy SM; Al-Tel TH; Omar HA J Pharm Pharmacol; 2021 Mar; 73(5):601-610. PubMed ID: 33772294 [TBL] [Abstract][Full Text] [Related]
60. Flavones: The Apoptosis in Prostate Cancer of Three Flavones Selected as Therapeutic Candidate Models. Jeong SH; Kim HH; Park MY; Bhosale PB; Abusaliya A; Won CK; Park KI; Kim E; Heo JD; Kim HW; Ahn M; Seong JK; Kim GS Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]